Typhoid Vaccine Market Report

Global Typhoid Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：191
  • REPORT CODE：GMM871304
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Typhoid Vaccine market report explains the definition, types, applications, major countries, and major players of the Typhoid Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • GlaxoSmithKline

    • Bharat Biotec

    • Merck

    • PaxVax

    • Sanofi

    • Merit Pharmaceuticals

    • Actiza Pharmaceutical

    By Type:

    • Oral Type

    • Injection Type

    By End-User:

    • Hospital

    • Research & Academic Laboratories

    • Pharmaceutical & Biotechnology Companies

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Typhoid Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Typhoid Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Typhoid Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Typhoid Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Typhoid Vaccine Market- Recent Developments

    • 6.1 Typhoid Vaccine Market News and Developments

    • 6.2 Typhoid Vaccine Market Deals Landscape

    7 Typhoid Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Typhoid Vaccine Key Raw Materials

    • 7.2 Typhoid Vaccine Price Trend of Key Raw Materials

    • 7.3 Typhoid Vaccine Key Suppliers of Raw Materials

    • 7.4 Typhoid Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Typhoid Vaccine Cost Structure Analysis

      • 7.5.1 Typhoid Vaccine Raw Materials Analysis

      • 7.5.2 Typhoid Vaccine Labor Cost Analysis

      • 7.5.3 Typhoid Vaccine Manufacturing Expenses Analysis

    8 Global Typhoid Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Typhoid Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Typhoid Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Typhoid Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Typhoid Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Type Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Injection Type Consumption and Growth Rate (2017-2022)

    • 9.2 Global Typhoid Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research & Academic Laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Typhoid Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Typhoid Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Typhoid Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Typhoid Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Typhoid Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Typhoid Vaccine Consumption (2017-2022)

      • 10.3.2 UK Typhoid Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Typhoid Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Typhoid Vaccine Consumption (2017-2022)

      • 10.3.5 France Typhoid Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Typhoid Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Typhoid Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Typhoid Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Typhoid Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Typhoid Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Typhoid Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Typhoid Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Typhoid Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Typhoid Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Typhoid Vaccine Consumption (2017-2022)

      • 10.4.3 India Typhoid Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Typhoid Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Typhoid Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Typhoid Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Typhoid Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Typhoid Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Typhoid Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Typhoid Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Typhoid Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Typhoid Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Typhoid Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Typhoid Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Typhoid Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Typhoid Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Typhoid Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Typhoid Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Typhoid Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Typhoid Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Typhoid Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Typhoid Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Typhoid Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Typhoid Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Typhoid Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Typhoid Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Typhoid Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Typhoid Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Typhoid Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Typhoid Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Typhoid Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Typhoid Vaccine Consumption (2017-2022)

    11 Global Typhoid Vaccine Competitive Analysis

    • 11.1 GlaxoSmithKline

      • 11.1.1 GlaxoSmithKline Company Details

      • 11.1.2 GlaxoSmithKline Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 GlaxoSmithKline Typhoid Vaccine Main Business and Markets Served

      • 11.1.4 GlaxoSmithKline Typhoid Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Bharat Biotec

      • 11.2.1 Bharat Biotec Company Details

      • 11.2.2 Bharat Biotec Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Bharat Biotec Typhoid Vaccine Main Business and Markets Served

      • 11.2.4 Bharat Biotec Typhoid Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Merck

      • 11.3.1 Merck Company Details

      • 11.3.2 Merck Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Merck Typhoid Vaccine Main Business and Markets Served

      • 11.3.4 Merck Typhoid Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 PaxVax

      • 11.4.1 PaxVax Company Details

      • 11.4.2 PaxVax Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 PaxVax Typhoid Vaccine Main Business and Markets Served

      • 11.4.4 PaxVax Typhoid Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Sanofi

      • 11.5.1 Sanofi Company Details

      • 11.5.2 Sanofi Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Sanofi Typhoid Vaccine Main Business and Markets Served

      • 11.5.4 Sanofi Typhoid Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Merit Pharmaceuticals

      • 11.6.1 Merit Pharmaceuticals Company Details

      • 11.6.2 Merit Pharmaceuticals Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Merit Pharmaceuticals Typhoid Vaccine Main Business and Markets Served

      • 11.6.4 Merit Pharmaceuticals Typhoid Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Actiza Pharmaceutical

      • 11.7.1 Actiza Pharmaceutical Company Details

      • 11.7.2 Actiza Pharmaceutical Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Actiza Pharmaceutical Typhoid Vaccine Main Business and Markets Served

      • 11.7.4 Actiza Pharmaceutical Typhoid Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Typhoid Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Typhoid Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Oral Type Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Injection Type Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Typhoid Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Research & Academic Laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Typhoid Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Typhoid Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Typhoid Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Typhoid Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Typhoid Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Typhoid Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Typhoid Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Typhoid Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Typhoid Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Typhoid Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Typhoid Vaccine

    • Figure of Typhoid Vaccine Picture

    • Table Global Typhoid Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Typhoid Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Oral Type Consumption and Growth Rate (2017-2022)

    • Figure Global Injection Type Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Research & Academic Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Typhoid Vaccine Consumption by Country (2017-2022)

    • Table North America Typhoid Vaccine Consumption by Country (2017-2022)

    • Figure United States Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Typhoid Vaccine Consumption by Country (2017-2022)

    • Figure Germany Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Typhoid Vaccine Consumption by Country (2017-2022)

    • Figure China Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Typhoid Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Typhoid Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Typhoid Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Typhoid Vaccine Consumption by Country (2017-2022)

    • Figure Australia Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Typhoid Vaccine Consumption and Growth Rate (2017-2022)

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Typhoid Vaccine Main Business and Markets Served

    • Table GlaxoSmithKline Typhoid Vaccine Product Portfolio

    • Table Bharat Biotec Company Details

    • Table Bharat Biotec Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bharat Biotec Typhoid Vaccine Main Business and Markets Served

    • Table Bharat Biotec Typhoid Vaccine Product Portfolio

    • Table Merck Company Details

    • Table Merck Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Typhoid Vaccine Main Business and Markets Served

    • Table Merck Typhoid Vaccine Product Portfolio

    • Table PaxVax Company Details

    • Table PaxVax Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table PaxVax Typhoid Vaccine Main Business and Markets Served

    • Table PaxVax Typhoid Vaccine Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Typhoid Vaccine Main Business and Markets Served

    • Table Sanofi Typhoid Vaccine Product Portfolio

    • Table Merit Pharmaceuticals Company Details

    • Table Merit Pharmaceuticals Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merit Pharmaceuticals Typhoid Vaccine Main Business and Markets Served

    • Table Merit Pharmaceuticals Typhoid Vaccine Product Portfolio

    • Table Actiza Pharmaceutical Company Details

    • Table Actiza Pharmaceutical Typhoid Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actiza Pharmaceutical Typhoid Vaccine Main Business and Markets Served

    • Table Actiza Pharmaceutical Typhoid Vaccine Product Portfolio

    • Figure Global Oral Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injection Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research & Academic Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Typhoid Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Typhoid Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Typhoid Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Typhoid Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Typhoid Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Typhoid Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Typhoid Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Typhoid Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Typhoid Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US